配备可切换CAR的转基因NK细胞用于治疗HER2阳性癌症
Maria A Streltsova1, Anna A Boyko1, Nadezhda A Alekseeva1
1Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 16/10 Miklukho-Maklaya Street, 117997, Moscow, Russia.
Biochimie
|July 23, 2025
概括
这项研究开发了可切换的仿制抗原受体 (CAR) NK-92细胞,针对HER2阳性癌症. 这些工程细胞展示了强大的和特定的瘤细胞杀伤,提供了灵活的"现成"癌症治疗平台.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 生物技术是生物技术.
背景情况:
- 化学抗原受体 (CAR) T细胞疗法显示出希望,但面临的挑战,如抗原逃逸和目标,瘤外毒性.
- 开发可适应和可控制的细胞免疫疗法对于提高癌症治疗疗效和安全至关重要.
研究的目的:
- 开发和描述一种新的,可切换的CAR系统,使用NK-92细胞向HER2阳性癌症.
- 在体外和3D瘤模型中评估这些工程NK-92细胞的疗效和特异性.
主要方法:
- 设计NK-92细胞以表达可切换CAR (BsCAR) 使用barnase-barstar相互作用系统.
- 与HER2特定的DARPin (Da-9.29-Bn) 结合的巴纳酶,以创建准模块.
- 通过流细胞测量评估CAR表达,通过脱粒试验,细胞溶解和3D球形模型评估细胞毒性潜力.
主要成果:
- 成功生成了具有适当表面表达的BsCAR-NK92细胞.
- 当HER2向模块存在时,BSCAR-NK92细胞对HER2高瘤细胞 (SKBR3,SKOV-Kat,BT-474) 呈现出显著和特定的细胞毒性.
- 在3D球形模型中维持了细胞毒性活性,并证实了针对HER2-低的MCF7细胞的特异性.
结论:
- BsCAR-NK92细胞代表了对HER2阳性癌症的可行的"现成"免疫疗法.
- 模块化的barnase-barstar系统允许灵活适应以准各种瘤抗原.
- 这种可切换的CAR平台为增强癌症治疗控制和特异性提供了一个有希望的策略.
关键词:
巴纳斯·巴纳斯 (Barnase) 是一个酒吧明星的酒吧明星在CAR-NK细胞中.在HER2中,HER2是HER2.NK-92 NK-92 NK-92 NK-92 NK-92 NK-92 NK-92 NK-92 NK-92 NK-92 NK-92 NK-92 NK-92 NK-92 NK-92 NK-92 NK-92 NK-92 NK-92 NK-92 NK-92 NK-92可切换的CAR可以切换.更多相关视频
09:56A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
800
08:29Engineering Chimeric Antigen Receptor-Natural Killer Cells Targeting Fungal Infections Using the Non-viral Sleeping Beauty Transposon System
Published on: October 4, 2024
899
相关概念视频
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
01:27Tumor Immunotherapy
664
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
664